is tirzepatide manjaro FDA approves new version of diabetes drug Mounjaro to be sold for weight loss Mounjaro (tirzepatide): Uses, Side Effects,

Sless, C

Landmark CVOT: The REWIND (Researching Cardiovascular Events with a Weekly Incretin in Diabetes) Key Findings: The REWIND trial was unique because it included a majority of patients who had risk factors for CVD but had not yet had a cardiovascular event (a primary prevention population)

Myocardial injury, troponin release, and cardiomyocyte death in brief ischemia, failure, and ventricular remodeling

Gastrointestinal Burden GLP-1 receptor agonists slow gastric emptying and directly act on the GI tract which is why nausea, vomiting, constipation, and diarrhoea are among the most commonly reported side effects, especially during dose escalation